The ethics and privacy concerns surrounding a new U.S. autism data project have sparked significant debate. Critics highlight that the criteria for diagnosing Autism Spectrum Disorder (ASD) have evolved, resulting in a rising diagnostic rate that reflects broader definitions rather than an actual increase in prevalence. There is a profound worry that the project could lead to the unethical use of data, with comparisons drawn to historical events reflecting poor ethical standards in health care and data management. In particular, comments point to the role of influential figures like Health and Human Services Secretary Robert F. Kennedy Jr. in perpetuating stigma against autism through misinformation about vaccines. Furthermore, alarming statistics indicate that the prevalence of ASD is notable, with significant concerns regarding the intellectual capabilities of diagnosed children. This situation raises questions about data privacy, stigmatization, and potential discrimination, emphasizing the necessity of ethical oversight in health data collection and use. Overall, the discourse around the project reflects broader societal tensions over data ethics, technology's role in health, and the implications of handling sensitive health-related data.